Saltar al contenido principal


Cursos disponibles

Ver detalle
07/05/2025 To 07/05/2026
Clinical practice
Ver detalle
04/29/2023
Acute lymphoblastic leukemia Acute Myeloid Leukemia Chronic lymphocytic leukemia Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Hodgkin lymphoma Lymphoid leukemias Multiple Myeloma Myelodysplastic Syndromes Non-Hodgkin lymphoma Plasma cell disorders Premalignant clonal myeloid disorders Research - Basic Science
Ver detalle
12/01/2023 To 11/30/2024
Acquired thrombophilias Autoimmune aplastic anemia and other acquired bone classical hematology Thrombotic disorders
Ver detalle
06/04/2021
Chronic lymphocytic leukemia Clonal lymphoid disorders Diffuse large B-cell lymphoma Emerging technologies follicular lymphoma Hodgkin lymphoma Lymphoid leukemias Non-Hodgkin lymphoma T-cell lymphomas Therapeutics - Targeted therapy
Ver detalle
09/13/2025 To 09/13/2026
Clinical practice health disparities Monoclonal gammopathy of undetermined significance Multiple Myeloma Patient experience Plasma cell disorders Racial and ethnic minorities Research - Population Science Treating fairly
Ver detalle
09/13/2025 To 09/13/2026
Autoimmune aplastic anemia and other acquired bone classical hematology Hematopoiesis and bone marrow failure syndromes
Ver detalle
12/07/2024 To 12/14/2027
Level 3 (Subspecialty): Fellows developing general hematology expertise for board certification
Research - Basic Science Research - Biostatistics Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational
Ver detalle
12/07/2024 To 12/14/2027
Research - Basic Science Research - Biostatistics Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational
Imagen del curso
MapleLMSImplementation
Cursos vinculados
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III, 636. Myelodysplastic Syndromes: Basic and Translational: Poster I, 636. Myelodysplastic Syndromes: Basic and Translational: Poster II, 636. Myelodysplastic Syndromes: Basic and Translational: Poster III, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster III, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster I, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster II, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I
Ver detalle
12/07/2024 To 12/14/2027
Acute myeloid leukemia (non-APL) Chronic myeloid leukemia Clonal myeloid disorders Myelodysplastic Syndromes Research - Basic Science Research - Clinical Research - Pre-Clinical Models Research - Translational Therapeutics - Immunotherapy Therapeutics - Targeted therapy Treatment-related acute myeloid leukemia
Ver detalle
12/07/2024 To 12/14/2027
Artificial intelligence (AI); machine learning; an bleeding disorders classical hematology Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Emerging technologies Hematopathology; laboratory medicine; images in he Hematopoietic stem cell transplantation and cellul Non-human populations - Animal models Plasma cell disorders Platelet disorders red cell disorders Research - Basic Science Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational Therapeutics - Biologics Therapeutics - Immunotherapy Therapeutics - Targeted therapy Transfusion medicine and apheresis
Ver detalle
12/07/2024 To 12/14/2027
bleeding disorders Health outcomes Platelet disorders Research - Basic Science Research - Clinical Research - Outcomes Research - Pre-Clinical Models Research - Translational Systems-based hematology Thrombotic disorders
Imagen del curso
MapleLMSImplementation
Cursos vinculados
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster II, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III, 102. Iron Homeostasis and Biology: Poster I, 102. Iron Homeostasis and Biology: Poster II, 102. Iron Homeostasis and Biology: Poster III, 112. Thalassemia and Globin Gene Regulation: Poster I, 112. Thalassemia and Globin Gene Regulation: Poster II, 112. Thalassemia and Globin Gene Regulation: Poster III, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III
Ver detalle
12/07/2024 To 12/14/2027
Clonal myeloid disorders Iron physiology and iron overload syndromes Normal iron physiology Normal red cell physiology Other inherited anemias Other topics in classical hematology Primary myelofibrosis red cell disorders Research - Basic Science Research - Biostatistics Research - Clinical Research - Outcomes Research - Population Science Research - Pre-Clinical Models Research - Translational Sickle cell disorders Thalassemias and other hemoglobin disorders Therapeutics - Biologics Therapeutics - Targeted therapy
Imagen del curso
MapleLMSImplementation
Cursos vinculados
901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster III, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster III, 904. Outcomes Research: Hemoglobinopathies: Poster I, 904. Outcomes Research: Hemoglobinopathies: Poster II, 904. Outcomes Research: Hemoglobinopathies: Poster III, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III, 907. Outcomes Research: Plasma Cell Disorders: Poster I, 907. Outcomes Research: Plasma Cell Disorders: Poster II, 907. Outcomes Research: Plasma Cell Disorders: Poster III, 908. Outcomes Research: Myeloid Malignancies: Poster I, 908. Outcomes Research: Myeloid Malignancies: Poster II, 908. Outcomes Research: Myeloid Malignancies: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Ver detalle
12/07/2024 To 12/14/2027
Clonal lymphoid disorders Clonal myeloid disorders Health outcomes Other acute myeloid leukemias Other lymphoid leukemias Research - Outcomes Research - Population Science Systems-based hematology
Imagen del curso
MapleLMSImplementation
Cursos vinculados
201. Granulocytes, Monocytes, and Macrophages: Poster I, 201. Granulocytes, Monocytes, and Macrophages: Poster II, 201. Granulocytes, Monocytes, and Macrophages: Poster III, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III, 701. Experimental Transplantation: Basic and Translational: Poster I, 701. Experimental Transplantation: Basic and Translational: Poster II, 701. Experimental Transplantation: Basic and Translational: Poster III, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster I, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster II, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster III, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster I, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster II, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster III, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster II, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III
Ver detalle
12/07/2024 To 12/14/2027
Acute Myeloid Leukemia classical hematology Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Emerging technologies health disparities Hematopoietic stem cell transplantation and cellul Myelodysplastic Syndromes Myeloproliferative Neoplasms Non-human populations - Animal models Pharmacology Primary myelofibrosis Quality and safety red cell disorders Research - Basic Science Research - Clinical Research - Outcomes Research - Population Science Research - Pre-Clinical Models Research - Translational Therapeutics - Biologics Therapeutics - Immunotherapy Therapeutics - Targeted therapy Transfusion medicine and apheresis
Imagen del curso
Cursos vinculados
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III, 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I, 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II, 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III, 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I, 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II, 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III, 621. Lymphomas: Translational – Molecular and Genetic: Poster I, 621. Lymphomas: Translational—Molecular and Genetic: Poster II, 621. Lymphomas: Translational—Molecular and Genetic: Poster III, 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I, 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II, 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III, 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Poster I, 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster II, 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster III, 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster I, 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster II, 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster III, 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster I, 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster II, 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster III, 641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster I, 641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster II, 641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster III, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III, 622. Lymphomas: Translational–Non-Genetic: Poster II, 622. Lymphomas: Translational–Non-Genetic: Poster III, 622. Lymphomas: Translational – Non-Genetic: Poster I
Imagen del curso
Cursos vinculados
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III, 613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I, 613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II, 613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III, 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I, 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II, 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III, 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I, 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II, 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III, 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I, 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II, 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III, 636. Myelodysplastic Syndromes – Basic and Translational: Poster I, 636. Myelodysplastic Syndromes—Basic and Translational: Poster II, 636. Myelodysplastic Syndromes—Basic and Translational: Poster III, 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Poster I, 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Poster II, 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster II
Imagen del curso
Cursos vinculados
301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster I, 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II, 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster III, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster I, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster II, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster III, 322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I, 322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster II, 322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster III, 331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-Related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster I, 331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster II, 331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster III, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III
Imagen del curso
Cursos vinculados
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster II, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III, 102. Iron Homeostasis and Biology: Poster I, 102. Iron Homeostasis and Biology: Poster II, 102. Iron Homeostasis and Biology: Poster III, 112. Thalassemia and Globin Gene Regulation: Poster I, 112. Thalassemia and Globin Gene Regulation: Poster II, 113. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I, 113. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II, 113. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III, 114. Sickle cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I, 114. Sickle cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II, 114. Sickle cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III, 112. Thalassemia and Globin Gene Regulation: Poster III
Imagen del curso
Cursos vinculados
201. Granulocytes, Monocytes, and Macrophages: Poster I, 201. Granulocytes, Monocytes, and Macrophages: Poster II, 201. Granulocytes, Monocytes, and Macrophages: Poster III, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III, 701. Experimental Transplantation: Basic and Translational: Poster I, 701. Experimental Transplantation: Basic and Translational: Poster II, 701. Experimental Transplantation: Basic and Translational: Poster III, 703. Cellular Immunotherapies: Basic and Translational: Poster I, 703. Cellular Immunotherapies: Basic and Translational: Poster II, 703. Cellular Immunotherapies: Basic and Translational: Poster III, 705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster I, 705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster II, 705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster III, 711. Cell Collection and Processing: Poster I, 711. Cell Collection and Processing: Poster II, 711. Cell Collection and Processing: Poster III, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster I, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster III, 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I, 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II, 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III, 723. Allogeneic Transplantation: Long-Term Follow-Up and Disease Recurrence: Poster I, 723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster II, 723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster III, 731. Autologous Transplantation: Clinical and Epidemiological: Poster I, 731. Autologous Transplantation: Clinical and Epidemiological: Poster II, 731. Autologous Transplantation: Clinical and Epidemiological: Poster III, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III, 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster I, 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster II, 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster III
Ver detalle
01/26/2023 To 01/26/2024
bleeding disorders classical hematology Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Emerging technologies Global health Guidelines health disparities Health economics Health outcomes Hematopathology; laboratory medicine; images in he Hematopoietic stem cell transplantation and cellul Human populations - Adults (age 18-64) Human populations - age 18 Human populations- older adults (age 65+) Human populations - Women; pregnancy; maternal hea Interdisciplinary collaboration Patient experience Plasma cell disorders Platelet disorders Racial and ethnic minorities red cell disorders Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational Supportive Care Survivorship Therapeutics - Biologics Therapeutics - Cytotoxic chemotherapy Therapeutics - Immunosuppression Therapeutics - Targeted therapy Thrombotic disorders Transfusion medicine and apheresis Treating fairly Underserved populations
Ver detalle
11/19/2019
Acquired iron overload states Acquired thrombophilias Adverse effects of transfusion Autoimmune aplastic anemia and other acquired bone Basics of transfusion medicine Clinical indications for transfusion Clinical practice Delayed non-immune (e.g. Guidelines health disparities Hematopathology Hematopoiesis and bone marrow failure syndromes Hematopoietic stem cell transplantation and cellul Human population Inherited anemias iron overload) Iron physiology and iron overload syndromes leukemia) Microvascular thrombosis Normal red cell physiology Other topics in classical hematology Patient experience Racial and ethnic minorities red cell disorders Sickle Cell Disease Sickle cell disorders Supportive Care Targeted therapy Thalassemias Therapeutics Thrombotic disorders Transfusion medicine and apheresis Transfusion support in hematologic disorders (e.g. Treating fairly Underserved populations
Ver detalle
10/04/2025 To 10/04/2026
Biostatistics research Clinical Research Grant writing Medical Education outcomes research Population science research Pre-clinical models
Ver detalle
02/24/2021
Research - Biostatistics Research - Clinical Research - Grant writing Research - Pre-Clinical Models
Ver detalle
12/12/2021
Adoptive cellular therapies Allogeneic hematopoietic stem cell transplantation Chimeric antigen receptor T-cell therapies health disparities Hematopoietic stem cell transplantation and cellul Research - Population Science Treating fairly
Ver detalle
07/05/2025 To 07/05/2026
Academic Basis science research Biostatistics research Clinical Research Grant writing Hematology workforce Interdisciplinary collaboration Medical Education Non-human populations - Animal models Peer-reviewed articles/publications Population science research Pre-clinical models research Research - Outcomes Systems-based hematology Translational research Underserved populations
Imagen del curso
Cursos vinculados
Platelets mediate the clearance of senescent red blood cells by forming pro-phagocytic platelet-cell complexes, Genomic Landscape of Patients with Germline RUNX1 Variants and Familial Platelet Disorder with Myeloid Malignancy, Regulation of lymphoid-myeloid lineage bias through Regnase-1/3-mediated control of Nfkbiz, First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis, Comparison of TP53 mutations in myelodysplasia and acute leukemia suggests divergent roles in initiation and progression, Less-deformable erythrocyte subpopulations biomechanically induce endothelial inflammation in sickle cell disease, DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma, Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice, Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association, Modeling and Targeting of Erythroleukemia by Hematopoietic Genome Editing, CRISPR-Edited Megakaryocytes for Rapid Screening of Platelet Gene Functions, Assembly of Alternative Prothrombinase by Extracellular Histones Initiates and Disseminates Intravascular Coagulation, IL-1 Mediates Microbiome-Induced Inflammaging of Hematopoietic Stem Cells in Mice, A STAT5B–CD9 Axis Determines Self-Renewal in Hematopoietic and Leukemic Stem Cells, Hypofibrinogenemia with Preserved Hemostasis and Protection from Thrombosis in Mice with an Fga Truncation Mutation, IL-13/IL-4 Signaling Contributes to Fibrotic Progression of the Myeloproliferative Neoplasms, Endothelial Cell–Leukemia Interactions Remodel Drug Responses, Uncovering T-ALL Vulnerabilities, IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells, Structural Basis of MPL Activation by Thrombopoietin, Adaptation to Ex Vivo Culture Reduces Human Hematopoietic Stem Cell Activity Independently of the Cell Cycle
Ver detalle
07/05/2025 To 07/05/2026
Acute Myeloid Leukemia Clonal myeloid disorders Emerging technologies Research - Basic Science Research - Clinical Research - Pre-Clinical Models Research - Translational Treatment-related acute myeloid leukemia
Ver detalle
04/18/2022
Acquired thrombophilias Anticoagulation Antithrombotic therapy Clinical practice Disorders of platelet number Guidelines health disparities Health economics Health outcomes Human populations - Adults (age 18-64) Human populations - age 18 Human populations- older adults (age 65+) immune thrombocytopenia Interdisciplinary collaboration Platelet disorders Quality and safety Racial and ethnic minorities red cell disorders Research - Population Science Sickle cell disorders Supportive Care Systems-based hematology Thromboembolism Thrombophilia Thrombotic disorders Treating fairly Venous thromboembolism
Ver detalle
01/25/2021
bleeding disorders Guidelines Inherited bleeding disorders Research - Clinical von Willebrand disease
Ver detalle
08/01/2020
Research - Biostatistics Research - Grant writing
Ver detalle
12/27/2022
Medical Education Medical Education Career Research - Grant writing
Ver detalle
12/19/2020 To 12/19/2021
CRTI application Medical Education Research - Biostatistics Research - Clinical Research - Grant writing
Ver detalle
11/17/2020
Acquired anemias Acquired iron overload states Acute Myeloid Leukemia Acute myeloid leukemia (non-APL) Allogeneic hematopoietic stem cell transplantation Anticoagulation classical hematology Clinical indications for transfusion Clinical practice Clinical Results Clonal myeloid disorders Delayed non-immune Disease Recurrence Disorders of platelet number Guidelines Hematopoietic stem cell transplantation and cellul Human populations- older adults (age 65+) Patient experience Platelet disorders Pre-transplant evaluation red cell disorders Research - Clinical Supportive Care Survivorship Therapeutics - Cytotoxic chemotherapy Therapeutics - Targeted therapy Thrombotic disorders Transfusion medicine and apheresis Transfusion support in hematologic disorders
Ver detalle
09/26/2025 To 09/26/2026
Research - Grant writing
Ver detalle
03/10/2024
Hematology workforce Medical Education Systems-based hematology
Ver detalle
12/27/2022
Medical Education Presentation skills Research - Grant writing
Ver detalle
03/27/2023
Research - Clinical Research - Population Science